Delivery of Large Biopharmaceuticals from Cardiovascular Stents: A Review
- 12 October 2007
- journal article
- review article
- Published by American Chemical Society (ACS) in Biomacromolecules
- Vol. 8 (11), 3281-3293
- https://doi.org/10.1021/bm700540p
Abstract
This review focuses on new and emerging large-molecule bioactive agents delivered from stent surfaces in drug-eluting stents (DESs) to inhibit vascular restenosis in the context of interventional cardiology. New therapeutic agents representing proteins, nucleic acids (small interfering RNAs and large DNA plasmids), viral delivery vectors, and even engineered cell therapies require specific delivery designs distinct from traditional smaller-molecule approaches on DESs. While small molecules are currently the clinical standard for coronary stenting, extension of the DESs to other lesion types, peripheral vasculature, and nonvasculature therapies will seek to deliver an increasingly sophisticated armada of drug types. This review describes many of the larger-molecule and biopharmaceutical approaches reported recently for stent-based delivery with the challenges associated with formulating and delivering these drug classes compared to the current small-molecule drugs. It also includes perspectives on possible future applications that may improve safety and efficacy and facilitate diversification of the DESs to other clinical applications.Keywords
This publication has 155 references indexed in Scilit:
- Angioscopic evaluation of neointima coverage: Sirolimus drug-eluting stent versus bare metal stentAmerican Heart Journal, 2006
- Overview of Pharmacology and Clinical Trials Program with the Zotarolimus‐Eluting Endeavor StentJournal of Interventional Cardiology, 2006
- Release of Plasmid DNA from Intravascular Stents Coated with Ultrathin Multilayered Polyelectrolyte FilmsBiomacromolecules, 2006
- Complementary effects of sirolimus-eluting stents and glycoprotein IIb/IIIa inhibitors for percutaneous coronary intervention in diabetic patients: one-year follow up of a single-centre registryHeart, 2006
- Cardiovascular gene delivery: The good road is awaitingAdvanced Drug Delivery Reviews, 2006
- Layer-by-layer assembly of cationic lipid and plasmid DNA onto gold surface for stent-assisted gene transferBiomaterials, 2006
- Low-Molecular-Weight HeparinsNew England Journal of Medicine, 1997
- Accelerated Endothelialization by Local Delivery of Recombinant Human Vascular Endothelial Growth Factor Reduces In-Stent Intimal FormationBiochemical and Biophysical Research Communications, 1997
- Identification of Integrins Involved in Cell Adhesion to Native and Denatured Type I Collagens and the Phenotypic Transition of Rabbit Arterial Smooth Muscle CellsExperimental Cell Research, 1995
- Antithrombotic Effects of Activated Protein C and Protein S in a Rabbit Model of Microarterial ThrombosisArteriosclerosis, Thrombosis, and Vascular Biology, 1995